Sat.Oct 24, 2020 - Fri.Oct 30, 2020

article thumbnail

Oxford start-up Base Genomics acquired by Exact Sciences

Pharma Times

Acquisition will enable Base Genomics to accelerate clinical and commercial development

150
150
article thumbnail

Ipsen’s UK MD on adapting business to COVID-19

pharmaphorum

Since entering the pharmaceutical industry as a graduate trainee in the late 1990s, Asad Mohsin Ali’s career has taken him across the business from Novartis, MSD and Tesaro, before joining global biopharma Ipsen. He tells us how the company has responded to COVID and how he’d like to see the UK industry grow in the future. As managing director, Ipsen UK & Ireland, Ali heads up one of Ipsen’s three global hubs, as well as chairing a UK & Ireland Site Steering Committee overseeing 900 peop

Hospitals 126
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

IQVIA: tap the right talent to lead digital transformation

Outsourcing Pharma

In order to effectively handle collection and analysis of huge volumes of vital data, a leader from IQVIA advises bringing on people up to the challenge.

126
126
article thumbnail

Top Considerations for Data Protection and Cybersecurity within the Pharmaceutical Industry

Pharma Marketing Network

The pharmaceutical industry deals with copious amounts of personal data, which means that adequate data protection and cybersecurity are non-negotiable. Even two years after the introduction of the General Data Protection Regulation (GDPR), the Information Commissioner Office is still fining companies who fail to fully protect their data. There are two sides of the data protection issue facing the pharma industry.

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Blood test more predictive of ovarian cancer than ‘previously thought’

Pharma Times

Findings come from new research funded by Cancer Research UK and NIHR

141
141
article thumbnail

What can we learn from women’s health data?

pharmaphorum

Analysing real-world health data could help overcome the bias towards men in traditional medical research, says Sensyne Health’s Dr Lucy Mackillop. Collecting and analysing anonymised patient data has the potential to generate valuable insights that can catalyse research, lead to improved patient care, and power the development of new treatments.

Diabetes 116

More Trending

article thumbnail

Gilead’s Covid-19 Drug is Mediocre. It Will Be a Blockbuster Anyway.

NY Times

Gilead Sciences said Wednesday that remdesivir, which has been authorized for emergency use since the spring, brought in $873 million in revenues so far this year.

85
article thumbnail

Parkinson’s UK partners with UCL on phase II trial

Pharma Times

Trial will investigate chemotherapy drug to alleviate hallucinations in people with Parkinson’s

article thumbnail

NIAID drops Lilly antibody from ACTIV-3 COVID-19 trial

pharmaphorum

Eli Lilly says no more patients will be treated with its COVID-19 therapy bamlanivimab in a trial run by the US National Institute of Allergy and Infectious Diseases (NIAID), as results to date suggest it is unlikely to be effective. The ACTIV-3 study was comparing bamlanivimab (also known as LY-CoV555 or LY3819253) and placebo when added to therapy with Gilead Sciences’ Veklury (remdesivir), which is already approved to treat COVID-19 requiring hospitalisation.

article thumbnail

FDA okays first COVID-19 treatment

Outsourcing Pharma

The agency has approved the antiviral drug Veklury (remdesivir), produced by Gilead, for hospitalized patients 12 years and over diagnosed with the virus.

Hospitals 105
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Which pharmaceutical companies have the most drug patents in Sweden?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Sweden. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Sweden? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

UK biotech consortium identifies COVID-19 antibody combinations

Pharma Times

The UK BIA Antibody Taskforce is set to take combinations into further development as a cocktail

136
136
article thumbnail

US buys Lilly COVID antibody, as effectiveness questions remain

pharmaphorum

The US government said it will buy 300,000 doses of Eli Lilly’s COVID-19 therapy bamlanivimab for $375 million if the drug gets Emergency Use Authorisation (EUA) – although its effectiveness has been called into question. The initial agreement is for delivery over the two months following an EUA, and provides the option for the government to purchase up to an additional 650,000 vials through 30 June 2021.

article thumbnail

Elligo: clinical trials can learn from healthcare

Outsourcing Pharma

During the CRAACO conference, a leader from the study solutions firm will discuss how researchers can learn and benefit from the other industry.

98
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

The Stressful Conclusion of a Clinical Trial

NY Times

Does a pharmaceutical company have a moral obligation to acknowledge my participation with an ongoing supply of the product that I helped test?

article thumbnail

UK’s MHRA starts rolling review of Moderna’s COVID-19 vaccine

Pharma Times

Process can help to reduce the time to authorisation of the vaccine

Vaccines 136
article thumbnail

Russia’s COVID-19 vaccine filed with WHO, as MHRA reviews Moderna shot

pharmaphorum

Russia’s sovereign wealth fund has filed applications with the World Health Organization (WHO) that if approved could see the Sputnik V coronavirus vaccine backed for use in many countries around the world. The applications are for two WHO mechanisms, aimed at providing a route to market for vaccines, drugs and other healthcare products that answer public health needs, particularly in low- and middle-income countries.

Vaccines 102
article thumbnail

CRAACO event unites clinical research and care

Outsourcing Pharma

This year the conference brings its content, focused on the intersection of clinical research and patient care, from the real world to the virtual one.

98
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

New patent expiration for Novartis drug TYZEKA

Drug Patent Watch

Annual Drug Patent Expirations for TYZEKA Tyzeka is a drug marketed by Novartis and is included in two NDAs. There are three patents protecting this drug. This drug has fifty-five…. The post New patent expiration for Novartis drug TYZEKA appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

Sanofi and GSK to provide COVID-19 vaccine doses to COVAX Facility

Pharma Times

Agreement will see vaccine developers make available 200 million doses

Vaccines 133
article thumbnail

NICE talking to you: Trends in early HTA engagement

pharmaphorum

With exclusive data from Freedom of Information (FOI) requests sent to the National Institute for Health and are Excellence (NICE), Leela Barham takes a look at the trend in early engagement with the UK’s HTA body. In 2009, NICE was one of the first health technology assessment (HTA) agencies to offer the opportunity for early scientific advice, at a cost.

article thumbnail

Care Access Research, Lilly join on mobile COVID-19 trials

Outsourcing Pharma

The clinical research solutions firm is joining forces with pharma giant Eli Lilly to manage mobile research of the monoclonal antibody LY-CoV555.

98
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

New patent expiration for LILLY drug CIALIS

Drug Patent Watch

Annual Drug Patent Expirations for CIALIS Cialis is a drug marketed by Lilly and is included in one NDA. It is available from seven suppliers. There is one patent protecting…. The post New patent expiration for LILLY drug CIALIS appeared first on DrugPatentWatch - Make Better Decisions.

55
article thumbnail

AZ’s Fasenra hits the mark in phase IIIb asthma trial

Pharma Times

Drug significantly eliminated oral corticosteroid (OCS) in OCS-dependent asthma patients

130
130
article thumbnail

Novartis CEO thinks 2nd health lockdown unlikely, as Q3 sales stabilise

pharmaphorum

Novartis’ pharmaceutical sales recovered in the third quarter of this year after an earlier COVID-19 decline, as new drugs like gene therapy Zolgensma gathered pace. . Correcting for currency fluctuations, net sales were flat at $12.3 billion for the quarter, but reduced spending allowed operating profit to climb 9% compared to the same period of 2019, coming in at $2.4 billion.

article thumbnail

WuXi STA: increasing demand fueling ‘robust’ HPAPI market

Outsourcing Pharma

A leader from the STA Pharmaceutical subsidiary of WuXI AppTec talks about the dynamic HPAPI market and whatâs ahead for their operation.

54
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

New patent for Lab Hra drug ELLA

Drug Patent Watch

Annual Drug Patent Expirations for ELLA Ella is a drug marketed by Lab Hra Pharma and is included in one NDA. It is available from one supplier. There are seven…. The post New patent for Lab Hra drug ELLA appeared first on DrugPatentWatch - Make Better Decisions.

53
article thumbnail

Novartis’ rare renal disease candidate shows promise in phase II

Pharma Times

Investigational oral treatment is being investigated in C3 glomerulopathy

121
121
article thumbnail

BioSig abandons COVID-19 drug trial on safety concerns

pharmaphorum

US biotech BioSig Technologies has abandoned a phase 2 trial of its antiviral drug merimepodib with Gilead’s Veklury in severe COVID-19 patients, after concluding the safety of the combination was in doubt. Shares in the company plunged more than 40% on the Nasdaq after the announcement, which revealed a difference in survival rates between the two groups enrolled into the study.

article thumbnail

Roche, Atea Pharmaceuticals partner on COVID-19 oral treatment

Outsourcing Pharma

The two companies are working together to develop AT-527, an orally administered, direct-acting antiviral therapy for patients diagnosed with COVID-19.

55
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.